المؤلفون: Rossi L., Biagioni C., McCartney A., Migliaccio I., Curigliano G., Sanna G., Moretti E., Minisini A. M., Cinieri S., Tondini C., Arpino G., Bernardo A., Martignetti A., Risi E., Pestrin M., Boni L., Benelli M., Biganzoli L., Di Leo A., Malorni L.

المساهمون: Rossi, L., Biagioni, C., Mccartney, A., Migliaccio, I., Curigliano, G., Sanna, G., Moretti, E., Minisini, A. M., Cinieri, S., Tondini, C., Arpino, G., Bernardo, A., Martignetti, A., Risi, E., Pestrin, M., Boni, L., Benelli, M., Biganzoli, L., Di Leo, A., Malorni, L.

مصطلحات موضوعية: Best sequence, CDK4/6 inhibitor, Metastatic breast cancer, Palbociclib, TREnd trial, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Female, Human, Kaplan-Meier Estimate, Piperazine, Postmenopause, Prognosi, Pyridine, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000469474800001; volume:21; issue:1; firstpage:71; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/11588/848496Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85066816663

الإتاحة: https://doi.org/10.1186/s13058-019-1149-5Test
http://hdl.handle.net/11588/848496Test

المؤلفون: Martel S., Poletto E., Ferreira A. R., Lambertini M., Sottotetti F., Bertolini I., Montemurro F., Bernardo A., Risi E., Zanardi E., Ziliani S., Mura S., Dellepiane C., Del Mastro L., Minisini A. M., Puglisi F.

المساهمون: Martel, S., Poletto, E., Ferreira, A. R., Lambertini, M., Sottotetti, F., Bertolini, I., Montemurro, F., Bernardo, A., Risi, E., Zanardi, E., Ziliani, S., Mura, S., Dellepiane, C., Del Mastro, L., Minisini, A. M., Puglisi, F.

مصطلحات موضوعية: Body mass index, HER2-positive, Metastatic breast cancer, Trastuzumab, Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Disease-Free Survival, Female, Human, Kaplan-Meier Estimate, Middle Aged, Neoplasm Metastasi, Proportional Hazards Model, Receptor, ErbB-2, Retrospective Studie, Survival Rate, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29161652; info:eu-repo/semantics/altIdentifier/wos/WOS:000418556700020; volume:37; firstpage:142; lastpage:147; numberofpages:6; journal:THE BREAST; http://hdl.handle.net/11571/1439651Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85034583267

الإتاحة: https://doi.org/10.1016/j.breast.2017.11.004Test
http://hdl.handle.net/11571/1439651Test

المؤلفون: Gerratana, L., Fanotto, V., Bonotto, M., Bolzonello, S., Minisini, A. M., Fasola, G., GERRATANA, Lorenzo, PUGLISI, Fabio

المساهمون: Gerratana, L., Fanotto, V., Bonotto, M., Bolzonello, S., Minisini, A. M., Fasola, G., Puglisi, Fabio, Gerratana, Lorenzo

مصطلحات موضوعية: Breast neoplasm, Immunophenotype, Metastatic spread, Outcome measure, Prognostic factor, Central Nervous System Neoplasm, Female, Human, Kaplan-Meier Estimate, Liver Neoplasm, Multivariate Analysi, Prognosi, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Regression Analysi, Retrospective Studie, Time Factor, Treatment Outcome, Neoplasm Metastasi, Cancer Research, Oncology, Medicine (all)

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000349548500003; volume:32; issue:2; firstpage:125; lastpage:133; numberofpages:9; journal:CLINICAL & EXPERIMENTAL METASTASIS; http://hdl.handle.net/11390/1067624Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84925539427

الإتاحة: https://doi.org/10.1007/s10585-015-9697-2Test
http://hdl.handle.net/11390/1067624Test

المؤلفون: PUGLISI, Fabio, Minisini, A. M., Angelis, C. D., Arpino, G.

المساهمون: Puglisi, Fabio, Minisini, A. M., Angelis, C. D., Arpino, G.

مصطلحات موضوعية: Antibodie, Monoclonal, Humanized, therapeutic use, Antineoplastic Agent, Breast Neoplasm, drug therapy/metabolism, Drug Resistance, Neoplasm, Female, Humans, Phosphatidylinositol 3-Kinase, metabolism, Quinazoline, Randomized Controlled Trials as Topic, Receptor, ErbB-2, Estrogen, Signal Transduction, drug effects

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000305773300002; volume:72; issue:9; firstpage:1175; lastpage:1193; numberofpages:19; journal:DRUGS; http://hdl.handle.net/11390/1045989Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84862118767; http://dx.doi.org/10.2165/11634000-000000000-00000Test

الإتاحة: https://doi.org/10.2165/11634000-000000000-00000Test
http://hdl.handle.net/11390/1045989Test

المؤلفون: PUGLISI, Fabio, Minisini, A. M.

المساهمون: Puglisi, Fabio, Minisini, A. M.

مصطلحات موضوعية: Animals, Antineoplastic Agent, Hormonal, therapeutic use, Breast Neoplasm, drug therapy/metabolism, Chemotherapy, Adjuvant, Humans, Postmenopause, Receptor, Estrogen, metabolism, Progesterone

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000287906100001; volume:77; firstpage:87; lastpage:99; numberofpages:13; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11390/1045991Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-78751612028; http://dx.doi.org/10.1016/j.critrevonc.2010.01.006Test

الإتاحة: https://doi.org/10.1016/j.critrevonc.2010.01.006Test
http://hdl.handle.net/11390/1045991Test